Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ENGN.NASDAQ

enGene Holdings Inc. Common Stock (ENGN NASDAQ) stock market data APIs

$9.05 0.05(0.6%) as of July 26, 2024
Price chart is built with Anychart

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

enGene Holdings Inc. Common Stock Financial Data Overview

9
9.05
-
9.75
8.5201
6.69-44
397 M
44 166 K
0
-0.38
-0.624
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ENGN',
Type: 'Common Stock',
Name: 'enGene Holdings Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01J1GCYW7',
ISIN: NULL,
CUSIP: '46429B226',
CIK: '1980845',
EmployerIdNumber: '',
FiscalYearEnd: 'October',
IPODate: '2023-11-01',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

enGene Holdings Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -44 523 000
  • Earnings Per Share -2.61
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get enGene Holdings Inc. Common Stock Earnings via APIs

  • Latest Release 2024-06-30
  • EPS/Forecast -0.26

Get enGene Holdings Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get enGene Holdings Inc. Common Stock latest news via APIs

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage...

Forbion co-leads €129 million Series A financing of VectorY, one of the largest private biotech financings in Europe in 2023

Round co-led by Forbion and EQT Life Sciences Financing will support clinical development of VTx-002, a potentially disease-modifying therapy for Amyotrophic Lateral Sclerosis (ALS) and additional pip...
  • FORBION
  • PRODUCT / SERVICES ANNOUNCEMENT
Do you have any questions?
support@eodhistoricaldata.com